1-4 of 4
Martin Soekler, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst, MD, Anna Maria Fink, MD, Raymonde Busch, Gabor Kovacs, MD, Christian Maurer, MD, Elisabeth Lange, MD, Hubert Köppler, Prof. Dr., Michael G Kiehl, MD, Martin Soekler, MD, Rudolf Schlag, Ursula Vehling-Kaiser, MD, Georg R.A. Köchling, MD, Christoph Plöger, MD, Michael Gregor, MD, Torben Plesner, MD, Marek Trneny, MD, Kirsten Fischer, Hartmut Döhner, MD, Michael Kneba, MD PhD, Clemens-Martin Wendtner, MD, Wolfram Klapper, MD, Karl Anton Kreuzer, Prof. Dr. MD, Stephan Stilgenbauer, MD PhD, Sebastian Böttcher, MD, Michael Hallek, MD
Journal: Blood
Blood (2014) 124 (21): 19.
https://doi.org/10.1182/blood.V124.21.19.19
Published: 2014
Journal Articles

Targeted Beacopp Variants In Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Interim Results Of a Randomized Phase II Study

Peter Borchmann, MD, Dennis A. Eichenauer, MD, Annette Plütschow, PhD, Stefanie Kreissl, MD, Michael Fuchs, MD, Martin Soekler, MD, Nicole Engel, MD, Julia Meissner, MD, Stephan Mathas, Karolin Behringer, MD, Markus Dietlein, MD, Carsten Kobe, MD, Volker Diehl, MD, Andreas Engert, MD
Journal: Blood
Blood (2013) 122 (21): 4344.
https://doi.org/10.1182/blood.V122.21.4344.4344
Published: 2013
Journal Articles

Blinatumomab Monotherapy Shows Efficacy in Patients with Relapsed Diffuse Large B Cell Lymphoma

Andreas Viardot, MD, Mariele Goebeler, MD, Richard Noppeney, MD, Stefan W. Krause, MD, Stefan Kallert, MD, Barbara Ferstl, MD, Andreas Mackensen, Kathrin Rupertus, MD, Martin Soekler, MD, Lothar Kanz, MD, Stefan Knop, MD, Max S. Topp, MD, Jurgen Scheele, MD, PhD, Dirk Nagorsen, MD, Gerhard Zugmaier, MD, Evelyn Degenhard, Margit Schmidt, PhD, Peter Kufer, MD, Martin Libicher, MD, Hermann Einsele, MD, Ralf Bargou, MD
Journal: Blood
Blood (2011) 118 (21): 1637.
https://doi.org/10.1182/blood.V118.21.1637.1637
Published: 2011
Journal Articles

A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas.

Eckhart Weidmann, MD, PhD, Georg Hess, MD, STefan W. Krause, MD, PhD, Marion Subklewe, MD, Judith Kruse, MD, Martin Soekler, MD, Katja Weisel, MD, Soo-Zin Kim, MD, Martin H. Dreyling, MD, PhD, Elke Jager, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2721.
https://doi.org/10.1182/blood.V108.11.2721.2721
Published: 2006